Eye Movement Disorders

Gold, Daniel R.

doi:10.1016/b978-0-323-34044-1.00016-x

Cited by 6 publications

(3 citation statements)

References 384 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Treatment of OGCs depends on the etiology of the condition [13]. In our case, the initial step required the removal of the offending agent or the reduction of its dosage.…”

Section: Discussionmentioning

confidence: 95%

Ziprasidone-Induced Oculogyric Crisis in a 74-Year-Old Female

Wilson

Filatov

Azhar

et al. 2020

Cureus

View full text Add to dashboard Cite

Oculogyric crisis is a rare ocular dystonia first appearing at the turn of the last century in postencephalitic patients. In the modern era, they were most frequently associated with firstgeneration D1 dopaminergic receptor blocking antipsychotic medication. We present an unusual case of acute oculogyric crisis in a 74-year-old woman with longstanding Parkinson disease following exposure to the second-generation neuroleptic ziprasidone, which has dopaminergic (D2) and serotoninergic (5-HT2A) receptor blocking effects and is used for severe delusions and psychosis. To the best of our knowledge, there are no other published reports.

show abstract

“…Treatment of OGCs depends on the etiology of the condition [13]. In our case, the initial step required the removal of the offending agent or the reduction of its dosage.…”

Section: Discussionmentioning

confidence: 95%

Ziprasidone-Induced Oculogyric Crisis in a 74-Year-Old Female

Wilson

Filatov

Azhar

et al. 2020

Cureus

View full text Add to dashboard Cite

show abstract

“…It is possible to classify it as either Infantile Nystagmus Syndrome (INS) or acquired nystagmus, depending on the severity. 4,5 It is estimated that there are 24 people in every 10,000 who have nystagmus in the UK. 5 In most cases, the initial symptoms of INS appear within the first six months of a person's life (the average age of onset is 1.9 months).…”

Section: Introductionmentioning

confidence: 99%

“…4,5 It is estimated that there are 24 people in every 10,000 who have nystagmus in the UK. 5 In most cases, the initial symptoms of INS appear within the first six months of a person's life (the average age of onset is 1.9 months). Depending on the underlying condition, children who experience nystagmus may have a visual acuity (VA) that is virtually normal or they may have a visual acuity that is substantially compromised.…”

Section: Introductionmentioning

confidence: 99%

Nystagmus in Childhood: A Systematic Review

Ratu Alicia

2023

JARMHS

View full text Add to dashboard Cite

Nystagmus is an involuntary rhythmic oscillation of the eyes that results in decreased visual acuity owing to the excessive motion of pictures on the retina. This is because nystagmus causes the eyes to move in a repetitive pattern. It is of the utmost importance to differentiate infantile nystagmus from acquired nystagmus. In order to accomplish this, it is necessary to take into consideration not only the time at which the nystagmus first appeared, but also the features of its waveform. Oscillations of the eyes that are involuntary, often conjugate, and frequently rhythmic are referred to as nystagmus. Infantile nystagmus syndrome (INS) is the condition that accounts for the majority of cases of nystagmus in children. Because this ailment can last a person's entire life, it is essential that they are familiar with all of the treatment choices that are at their disposal. The primary foci of this review are the underlying etiology of nystagmus, the psychosocial and functional implications of nystagmus, and the current methods of treatments, which include optical, pharmacological, surgical, and rehabilitative treatment approaches. At this time, the brain mechanisms that are responsible for INS are not completely known. The evidence is limited to mostly pre- and post-study designs, and there are few objective comparisons of treatment procedures. The treatment choices are meant to increase the foveation length or correct abnormal head positions. Individualized management of INS should be implemented. The patient and the patient's physician are the ones who should make the decision regarding which treatment will be most beneficial for the patient in question.

show abstract